Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. scores highest on Torque (50) and lowest on Anchor (24). Its PosiPenta is 35.22 out of 100, weaker than most similar companies.
On the Penta Grid this week, Black Diamond Therapeutics, Inc. is Grid #665 of 837 in the Healthcare sector in United States, and Grid #3,285 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | 35.22 | 39 | 34 | 28 | 50 | 24 |
| Foghorn Therapeutics Inc. | 37.76 | 0 | 36 | 20 | 94 | 39 |
| Owlet, Inc. | 35.91 | 21 | 74 | 11 | 32 | 42 |
| Definitive Healthcare Corp. | 41.42 | 43 | 60 | 36 | 28 | 39 |
| Humacyte, Inc. | 29.23 | 17 | 60 | 26 | 8 | 35 |
| Voyager Therapeutics, Inc. | 38.74 | 43 | 39 | 19 | 44 | 49 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.29 |
| P/B ratio | 1.03 |
EEarnings
| Trailing EPS | ₹-71.04 |
| Forward EPS | ₹-94.72 |
NNitro
| Price | 162.91 |
| 52-week high | 467.89 |
| 52-week low | 151.54 |
| Fall from 52-week high | 65.2% |
TTorque
| Return on equity (ROE) | -37.22% |
| Debt-to-equity | 0.18 |
AAnchor
| Beta (price swings) | 3.33 |
| Market cap | ₹933 Cr |
| Insider holding | 0.66% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Black Diamond Therapeutics, Inc.'s PosiPenta score?
Black Diamond Therapeutics, Inc.'s PosiPenta is 35.22 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Black Diamond Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Black Diamond Therapeutics, Inc. is Grid #665 of 837 in the Healthcare sector in United States, and Grid #3,285 of 4,000 in United States.
Which PosiPenta pillar is strongest for Black Diamond Therapeutics, Inc.?
Torque (durability), with a score of 50 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Black Diamond Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 24 out of 100: weaker than most similar companies.
Has Black Diamond Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.79 points, from 31.43 to 35.22.
PositoAI is for research and education only and is not investment advice.